Eszopiclone
- Product NDC
- 53217-151
- 11-digit product format
- 532170151
- Labeler code
- 53217
- Product ID
- 53217-151_9ca75b79-bb7f-41a6-91fd-76abb78bb939
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Eszopiclone
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Aidarex Pharmaceuticals LLC
- Application
- ANDA202929
- Marketing category
- ANDA
- Marketing start
- 2014-04-25
- Marketing end
- 0000-00-00
- Substance
- ESZOPICLONE
- Active strength
- 3 mg/1
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 53217-151 | I | Inactivated by FDA | 2026-08-03 | ||
| excluded package | package | 53217-151 | 53217-151-30 | I | Inactivated by FDA | 2026-08-03 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | 53217-151 | I | Inactivated by FDA | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… | ||
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 53217-151 | 53217-151-30 | I | Inactivated by FDA | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | 53217-151 | I | Inactivated by FDA | excluded / ndc_excluded.zip | f5e01cc5f278… | a2eaf40c39c3… | ||
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 53217-151 | 53217-151-30 | I | Inactivated by FDA | excluded / ndc_excluded.zip | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 53217-151 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 2ef7874e63bc… | 57b86245f4fa… | ||
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 53217-151 | 53217-151-30 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | 53217-151 | I | Inactivated by FDA | excluded / ndc_excluded.zip | a1b67e2a42f9… | c4cf2c586c0d… | ||
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 53217-151 | 53217-151-30 | I | Inactivated by FDA | excluded / ndc_excluded.zip | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | 53217-151 | I | Inactivated by FDA | excluded / ndc_excluded.zip | cfe11265f3b6… | 090c488252e2… | ||
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 53217-151 | 53217-151-30 | I | Inactivated by FDA | excluded / ndc_excluded.zip | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | 53217-151 | I | Inactivated by FDA | excluded / ndc_excluded.zip | cdf11ea48f46… | ba0047e9e063… | ||
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 53217-151 | 53217-151-30 | I | Inactivated by FDA | excluded / ndc_excluded.zip | cdf11ea48f46… | ba0047e9e063… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 53217-151 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 302b2466d912… | e7b80fea0513… | ||
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 53217-151 | 53217-151-30 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 302b2466d912… | e7b80fea0513… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | 53217-151 | I | Inactivated by FDA | excluded / ndc_excluded.zip | ed331223b511… | 672a5bd82f5f… | ||
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 53217-151 | 53217-151-30 | I | Inactivated by FDA | excluded / ndc_excluded.zip | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 53217-151 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 0efc9e666f02… | f202fb6c5f17… | ||
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 53217-151 | 53217-151-30 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 0efc9e666f02… | f202fb6c5f17… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | 53217-151 | I | Inactivated by FDA | excluded / ndc_excluded.zip | ad56d346431e… | cc804d4bbf1e… | ||
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 53217-151 | 53217-151-30 | I | Inactivated by FDA | excluded / ndc_excluded.zip | ad56d346431e… | cc804d4bbf1e… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 53217-151 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 367a005e9d99… | 383a685ebd0f… | ||
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 53217-151 | 53217-151-30 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 367a005e9d99… | 383a685ebd0f… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 53217-151 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 557ba5c1ecfa… | 9c80585c8c6e… | ||
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 53217-151 | 53217-151-30 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | 53217-151 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 8af77b9d5b6f… | d9bbb34c5368… | ||
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 53217-151 | 53217-151-30 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | 53217-151 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 834df4deac94… | adcc014656a3… | ||
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 53217-151 | 53217-151-30 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 834df4deac94… | adcc014656a3… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 53217-151 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 1332a3947898… | d4bfe170f9cd… | ||
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 53217-151 | 53217-151-30 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 1332a3947898… | d4bfe170f9cd… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | 53217-151 | I | Inactivated by FDA | excluded / ndc_excluded.zip | fb8cb913e6d1… | eb8c232b6be0… | ||
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 53217-151 | 53217-151-30 | I | Inactivated by FDA | excluded / ndc_excluded.zip | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | 53217-151 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 86f5da6cb304… | a595104c45d7… | ||
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 53217-151 | 53217-151-30 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | 53217-151 | I | Inactivated by FDA | excluded / ndc_excluded.zip | bd6a592717d7… | 303034d00443… | ||
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 53217-151 | 53217-151-30 | I | Inactivated by FDA | excluded / ndc_excluded.zip | bd6a592717d7… | 303034d00443… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | 53217-151 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 8dfbde2a14a4… | c9ff85d89658… | ||
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 53217-151 | 53217-151-30 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 8dfbde2a14a4… | c9ff85d89658… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | 53217-151 | I | Inactivated by FDA | excluded / ndc_excluded.zip | e2bbac7714bc… | 27bdfed8d636… | ||
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 53217-151 | 53217-151-30 | I | Inactivated by FDA | excluded / ndc_excluded.zip | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded product | product | 53217-151 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 9bebd1f3094a… | 5416666fcb17… | ||
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 53217-151 | 53217-151-30 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 9bebd1f3094a… | 5416666fcb17… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A202929-001 | ESZOPICLONE | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2015-01-30 | |
| A202929-002 | ESZOPICLONE | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2015-01-30 | |
| A202929-003 | ESZOPICLONE | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2015-01-30 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A202929-001 | AB |
| A202929-002 | AB |
| A202929-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A202929-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2015-01-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A202929-002 | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2015-01-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A202929-003 | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2015-01-30 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202929-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2015-01-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202929-002 | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2015-01-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202929-003 | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2015-01-30 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A202929-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2015-01-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A202929-002 | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2015-01-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A202929-003 | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2015-01-30 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202929-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2015-01-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202929-002 | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2015-01-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202929-003 | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2015-01-30 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202929-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2015-01-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202929-002 | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2015-01-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202929-003 | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2015-01-30 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202929-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2015-01-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202929-002 | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2015-01-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202929-003 | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2015-01-30 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202929-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2015-01-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202929-002 | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2015-01-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202929-003 | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2015-01-30 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A202929-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2015-01-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A202929-002 | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2015-01-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A202929-003 | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2015-01-30 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A202929-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2015-01-30 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A202929-002 | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2015-01-30 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A202929-003 | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2015-01-30 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A202929-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2015-01-30 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A202929-002 | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2015-01-30 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A202929-003 | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2015-01-30 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202929-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2015-01-30 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202929-002 | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2015-01-30 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202929-003 | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2015-01-30 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202929-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2015-01-30 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202929-002 | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2015-01-30 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202929-003 | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2015-01-30 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A202929-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2015-01-30 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A202929-002 | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2015-01-30 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A202929-003 | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2015-01-30 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A202929-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2015-01-30 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A202929-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A202929-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A202929-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202929-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202929-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202929-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A202929-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A202929-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A202929-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202929-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202929-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202929-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202929-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202929-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202929-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202929-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202929-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202929-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202929-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202929-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202929-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A202929-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A202929-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A202929-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A202929-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A202929-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A202929-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A202929-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A202929-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A202929-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202929-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202929-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202929-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202929-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202929-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202929-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A202929-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A202929-002 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A202929-003 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A202929-001 | AB | 1 | 8072bd15b7f6… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Eszopiclone | ESZOPICLONE | Preferred Pharmaceuticals Inc. | 2b5b4fbb-9b86-46c6-9508-37d3d9806dec | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | 202929 ANDA202929 |
| Eszopiclone | ESZOPICLONE | REMEDYREPACK INC. | 61fd4655-060f-4393-a610-019d8b127058 | 2026-04-13 | Boxed warning, Warnings, Adverse reactions | 202929 ANDA202929 |
| Eszopiclone | ESZOPICLONE | Preferred Pharmaceuticals Inc. | abe3a610-a25d-4b52-8537-c87e8ba3104a | 2026-04-13 | Boxed warning, Warnings, Adverse reactions | 202929 ANDA202929 |
| ESZOPICLONE | ESZOPICLONE | DIRECT RX | 486b760b-7fea-306b-e054-00144ff8d46c | 2026-03-05 | Warnings, Adverse reactions | 202929 ANDA202929 |
| Eszopiclone | ESZOPICLONE | Bryant Ranch Prepack | f6022b2f-9b43-40cc-91c7-c224b209efab | 2025-09-24 | Boxed warning, Warnings, Adverse reactions | 202929 ANDA202929 |
| Eszopiclone | ESZOPICLONE | REMEDYREPACK INC. | 9dfe774a-2c7a-4e10-bedd-cde64ad28676 | 2025-07-24 | Boxed warning, Warnings, Adverse reactions | 202929 ANDA202929 |
| Eszopiclone | ESZOPICLONE | Asclemed USA, Inc. | 10175591-c1b4-461a-830e-8df982d0d2bf | 2025-02-12 | Boxed warning, Warnings, Adverse reactions | 202929 ANDA202929 |
| Eszopiclone | ESZOPICLONE | Preferred Pharmaceuticals Inc. | be25bb4e-d84f-4396-a78f-a668a207cf2d | 2025-02-10 | Boxed warning, Warnings, Adverse reactions | 202929 ANDA202929 |
| Eszopiclone | ESZOPICLONE | Advanced Rx of Tennessee, LLC | af86fca8-571a-0cac-e053-2a95a90ae402 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 202929 ANDA202929 |
| Eszopiclone | ESZOPICLONE | Advanced Rx of Tennessee, LLC | af863d89-25db-2893-e053-2a95a90a704c | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 202929 ANDA202929 |
| Eszopiclone | ESZOPICLONE | Advanced Rx Pharmacy of Tennessee, LLC | c8ae09eb-4c9b-4560-e053-2995a90a02b1 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 202929 ANDA202929 |
| Eszopiclone | ESZOPICLONE | Lake Erie Medical DBA Quality Care Products LLC | 9460be93-cd53-4429-a4d9-2f04e3835168 | 2024-12-18 | Warnings, Adverse reactions | 202929 ANDA202929 |
| Eszopiclone | ESZOPICLONE | Quality Care Products LLC | 3b8a09c6-0702-43a7-b47f-a36cd00b7584 | 2024-12-17 | Warnings, Adverse reactions | 202929 ANDA202929 |
| Eszopiclone | ESZOPICLONE | Quality Care Products LLC | 7832f554-2b82-4ef2-b1ef-266179f271d3 | 2024-12-17 | Warnings, Adverse reactions | 202929 ANDA202929 |
| Eszopiclone | ESZOPICLONE | Bryant Ranch Prepack | 9a891ab1-675f-498e-a21e-05964307d2dd | 2024-08-07 | Boxed warning, Warnings, Adverse reactions | 202929 ANDA202929 |
| Eszopiclone | ESZOPICLONE | NuCarePharmaceuticals, Inc. | 53fcee89-027a-13e5-e054-00144ff8d46c | 2024-07-10 | Warnings, Adverse reactions | 202929 ANDA202929 |
| Eszopiclone | ESZOPICLONE | Proficient Rx LP | d301b0cf-1492-4be9-83a0-1b64c8fa3b72 | 2023-07-01 | Warnings, Adverse reactions | 202929 ANDA202929 |
| Eszopiclone | ESZOPICLONE | Macleods Pharmaceuticals Limited | 12593790-e72f-45b1-8895-987cdd075134 | 2022-10-29 | Boxed warning, Warnings, Adverse reactions | 202929 ANDA202929 |
| Eszopiclone | ESZOPICLONE | Proficient Rx LP | 5451be60-1315-4152-ad13-412e86903c8a | 2022-07-01 | Warnings, Adverse reactions | 202929 ANDA202929 |
| Eszopiclone | ESZOPICLONE | Proficient Rx LP | 1582ba77-a4e3-464f-876b-28cc7e41e8f1 | 2020-02-01 | Warnings, Adverse reactions | 202929 ANDA202929 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f65008ed-f925-2246-581a-e6a3201df7e4 | Product name | 5 | 20250107 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 53217-151-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-81cd-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use eszopiclone tablets safely and effectively. See full prescribing information for eszopiclone tablets. Eszopiclone tablets, for oral use, CIV Initial U.S. Approval: 2004 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53217-151-30 | Eszopiclone | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 53217-151-30 | EA - Each | 53217-151 | 2d42d24f-60c0-4d7d-88c0-803c78ab6293 | 1 | 2017-03-06 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 485465 | eszopiclone 3 MG Oral Tablet | PSN | 421c9fa7-107c-4265-9a7b-ac606b5c9923 | 1 |
| 485465 | eszopiclone 3 MG Oral Tablet | SCD | 421c9fa7-107c-4265-9a7b-ac606b5c9923 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 53217-151-30 | 53217015130 | 30 in 1 BOTTLE | Historical |